This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

J. Michael Lane, MD, MPH; Frederick L. Ruben, MD; Elias Abrutyn, MD; J. Donald Millar, MD, DTPH

JAMA. 1970;212(3):441-444.

Abstract
There were 68 deaths in the United States from complications of smallpox vaccination in the nine years 1959 to 1966, and 1968; 19 were associated with vaccinia necrosum, 36 were caused by postvaccinial encephalitis, 12 by eczema vaccinatum, and 1 by Stevens-Johnson syndrome. Of the 68 who died, 24 were infants, although only 12% of all primary vaccinations are given to this age group. All of the deaths from eczema vaccinatum were in children who were not vaccinated themselves, but acquired vaccinia from a sibling, playmate, or parent. This suggests that reduction of the number of deaths from eczema vaccinatum cannot be established by screening vaccinees alone. Reducing the number of primary vaccinations performed would lower the risks of acquiring eczema vaccinatum and postvaccinial encephalitis.

Author Affiliations
From the Smallpox Eradication Program, National Communicable Disease Center, Atlanta. Dr. Lane is now with University of California School of Public Health, Berkeley.

Footnotes
Reprint requests to 1600 Clifton Rd, Atlanta 30333 (Dr. Ruben).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
Casey et al.
JAMA 2005;294:2734-2743.
ABSTRACT | FULL TEXT  

Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002-2004
Sejvar et al.
JAMA 2005;294:2744-2750.
ABSTRACT | FULL TEXT  

Biological Activity of an Intravenous Preparation of Human Vaccinia Immune Globulin in Mouse Models of Vaccinia Virus Infection
Shearer et al.
Antimicrob. Agents Chemother. 2005;49:2634-2641.
ABSTRACT | FULL TEXT  

Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus
Stittelaar et al.
J. Virol. 2005;79:7845-7851.
ABSTRACT | FULL TEXT  

Smallpox vaccination and myopericarditis: a clinical review
Cassimatis et al.
J Am Coll Cardiol 2004;43:1503-1510.
ABSTRACT | FULL TEXT  

Smallpox: Clinical Features, Prevention, and Management
Guharoy et al.
The Annals of Pharmacotherapy 2004;38:440-447.
ABSTRACT | FULL TEXT  

Encephalitis Complicating Smallpox Vaccination
Miravalle and Roos
Arch Neurol 2003;60:925-928.
ABSTRACT | FULL TEXT  

Smallpox Vaccine: The Good, the Bad, and the Ugly
Belongia and Naleway
Clin Med Res 2003;1:87-92.
ABSTRACT | FULL TEXT  

Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options
Lane and Goldstein
ANN INTERN MED 2003;138:488-493.
ABSTRACT | FULL TEXT  

How Contagious Is Vaccinia?
Sepkowitz
NEJM 2003;348:439-446.
FULL TEXT  

A Different View of Smallpox and Vaccination
Mack
NEJM 2003;348:460-463.
FULL TEXT  

Contact Vaccinia--Transmission of Vaccinia From Smallpox Vaccination
Neff et al.
JAMA 2002;288:1901-1905.
FULL TEXT  

Responses to Smallpox Vaccine
Sauri et al.
NEJM 2002;347:689-690.
FULL TEXT  

Progressive Vaccinia Associated With Combined Variable Immunodeficiency
Keane et al.
Arch Dermatol 1983;119:404-408.
ABSTRACT  

Herpetic Meningitis (Type 1) in a Case of Acute Leukemia
Cappel and Klastersky
Arch Neurol 1973;28:415-416.
ABSTRACT  

Chronic Localized Nonprogressive Vaccinia During Infectious Hepatitis
Taylor et al.
Arch Pediatr Adolesc Med 1971;121:420-422.
ABSTRACT